A €16.99 Korean sunscreen just outsold every heritage beauty brand on Amazon Germany — and the market implications stretch well beyond skincare aisles.
K-beauty Germany reached a symbolic milestone on 28 May 2026, when COSRX’s Ultra-Light Invisible Sunscreen SPF50+ PA++++ claimed the No. 1 spot across the entire beauty category on Amazon.de — not just sunscreens, but all beauty products. The brand, a 93.2%-owned subsidiary of South Korea’s Amorepacific (KRX: 090430), had already topped Amazon UK’s sunscreen chart for four consecutive weeks beginning 14 April. Crossing into Germany, Europe’s largest economy and home to some of the continent’s most established skincare houses, is a different proposition entirely.
The displacement is most notable for what it says about incumbents. Beiersdorf AG, the Hamburg-based owner of Nivea and Eucerin, has dominated German pharmacy and mass-market sun care for decades. La Roche-Posay, owned by L’Oréal, holds the premium-dermatological lane. Yet a Korean entrant priced at €16.99 — undercutting most German pharmacy SPF50 products — gathered 1,489 customer reviews and a 4.5-star rating on Amazon.de in a matter of weeks, according to figures cited in COSRX’s own EQS NEWS disclosure. Single-product chart positions are volatile and should not be read as permanent market-share shifts, but the speed of the climb is worth watching.
The parent-company numbers add context. Amorepacific reported record consolidated revenue of KRW 4.62 trillion for 2025, with operating profit rising 47.6% year-over-year to KRW 368 billion — the group’s highest in six years. The standout line was overseas operating profit, which surged 102% year-over-year to roughly KRW 210 billion. Europe and the Americas, not the traditional Greater China corridor, drove the acceleration. COSRX’s integration as a subsidiary following Amorepacific’s KRW 755.1 billion acquisition in late 2023 has made it a key vector for that Western push, with Amazon serving as the primary channel.
Zooming out, the European K-beauty products market was valued at approximately USD 2.9 billion in 2026 and is projected to reach USD 5 billion by 2035 at a compound annual growth rate of 6.4%, according to Global Market Insights. Germany alone is forecast to nearly double from roughly USD 930 million in 2023 to USD 1.94 billion by 2032. Amorepacific led European K-beauty with over 12% market share in 2025. For investors holding Beiersdorf or L’Oréal, the question is less about a single Amazon chart day and more about whether digital-first Korean brands can systematically convert social-media virality — COSRX’s cumulative TikTok hashtag views have exceeded 2.1 billion since 2022 — into sustained shelf share in a market that German and French conglomerates have historically treated as a home advantage.
That conversion is not guaranteed. Amazon bestseller rankings reset frequently, and a chart-topping run during a seasonal sunscreen surge does not equate to year-round dominance in pharmacy and Drogeriemarkt channels where Beiersdorf’s distribution network remains formidable. EU cosmetics regulation, overseen by BaFin on the financial side and the European Commission on product safety, also introduces compliance costs that can slow foreign entrants scaling physical retail. Still, Amorepacific’s 8.5% group revenue growth against a backdrop of tightening consumer spending across the eurozone suggests the K-beauty thesis has moved past the novelty stage.
For shareholders tracking this space, the meaningful data point is not the No. 1 badge itself but the margin profile: Amorepacific’s prestige lines carry gross margins in the 70% range, and COSRX’s direct-to-consumer Amazon model avoids the distributor markups that erode profitability in traditional retail. Whether that advantage holds as the brand pursues brick-and-mortar expansion across Douglas stores in Germany and Austria — a channel Amorepacific has been entering — will shape the next chapter. Related: German consumer-goods earnings to watch this quarter.
This article is journalism and educational commentary, not investment advice. The author is not a BaFin-registered investment adviser (Anlageberater). Figures should be independently verified against official filings before any financial decision.
Found this analysis useful? Share it with a fellow investor who tracks European consumer plays.
